{"nct_id":"NCT01127893","title":"Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis","status":"TERMINATED","status_verified_date":"2021-02","start_date":"2010-06-15","start_date_type":"ACTUAL","primary_completion_date":"2010-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2010-09-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}